New patent expiration for Astrazeneca Ab drug BYDUREON
April 9, 2023 Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.
New patent expiration for Astrazeneca Ab drug BYDUREON
Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.